AI Newswire (Page 141)

VKTR brings you the day-to-day news announcements from companies across the artificial intelligence (AI) market — including their new products, partnerships, client engagements, mergers and acquisitions, fundings and executives.
Press Release
Digital Experience
USSOCOM Awards OTA Agreement to Beacon AI to Improve Aircraft Routing and Safety
Feb 22, 2024
MACDILL AIR FORCE BASE, Fla., Feb. 22, 2024 /PRNewswire/ -- Beacon AI, an artificial intelligence aviation technology company, was awarded a Phase 2 prototype Other Transaction Authority (OTA) agreement from U.S. Special Operations Command to enhance their AI copilot assistant to optimize aircraft operations and improve aircraft route selection.
Press Release
Digital Experience
RhythmX AI and Sentara Health Announce Groundbreaking Collaboration to Forge the Future of Primary Care with Predictive and Generative AI-driven Copilot for Clinicians
Feb 22, 2024
Partnering for Hyper-Personalized Healthcare Innovation: Revolutionary precision care platform by RhythmX AI will allow patients to access high-quality care more broadly with the right clinician at the right place at the right time PALO ALTO, Calif., Feb. 22, 2024 /PRNewswire/ -- RhythmX AI, a generative AI-native company driving revolutionary physician intelligence for whole-person care through cutting-edge predictive and generative AI, announced a strategic partnership with Virginia -based Sentara Health, one of the top 20 largest not-for-profit integrated health care delivery systems in the country. "We are going after a big, shared vision that truly reshapes healthcare," said RhythmX AI CEO Deepthi Bathina Together, RhythmX AI and Sentara are building the next generation of hyper-personalized primary care for clinicians and patients. With RhythmX AI's predictive and generative AI platform, Sentara primary care clinicians will have access to next-best clinical actions surfaced directly from the relevant clinical and payor guidelines, earlier disease detection, underlying EMR data analyses, and documentation support.
Press Release
Digital Experience
New ISC2 Study Reveals Impact of AI on Cyber Professionals and Urgent Need for Preparedness
Feb 22, 2024
ISC2 to launch AI educational workshops, bringing together industry experts and professionals to share practical solutions for addressing our top AI challenges ALEXANDRIA, Va., Feb. 22, 2024 /PRNewswire/ -- ISC2 – the world's leading nonprofit member organization for cybersecurity professionals – today announced findings from its latest study, AI in Cyber 2024: Is the Cybersecurity Profession Ready?, revealing the real-world impacts that artificial intelligence (AI) has had on cybersecurity. With responses from more than 1,100 cybersecurity professionals, 88% of respondents believe that AI will significantly impact their jobs, now or in the near future, and 35% have already witnessed its effects.
Press Release
Digital Experience
Loora Raises $12M to Break Down Barriers to English Fluency with Generative AI
Feb 21, 2024
The funds will be used to deepen the company's conversational AI technology and expand its global team and operations, allowing more people to easily learn English to advance their personal and professional lives TEL AVIV, Israel, Feb. 21, 2024 /PRNewswire/ -- Loora, the generative AI English language learning company, announced today that it raised $12M in a Series A financing round from lead investor QP Ventures, with participation from new investor Hearst Ventures and existing investors Emerge and Two Lanterns Venture Partners, among others. The new funding, which comes just eight months after Loora's launch from stealth with a $9.25M seed funding round, will enable the company to expand its team, advance the proprietary AI capabilities fueling its mobile app platform, and extend its market reach to new audiences in the coming months.
Press Release
Digital Experience
More Than 300 International Experts Release Open Letter Demanding Government Leaders Take Immediate Action to Combat Deepfake Threats
Feb 21, 2024
BERKELEY, Calif., Feb. 21, 2024 /PRNewswire/ -- More than 300 leading international experts in technology, artificial intelligence, digital ethics, and child safety, as well as entertainment professionals and academics today issued an open letter urging governments, policymakers, and political leaders to combat the growing threat of harmful deepfake content, which often involves sexual imagery, fraud, or political disinformation. Signatories on the letter include prominent thought leaders such as Andrew Yang, Joy Buolamwini, Stuart Russell, Sarah Gardner, Gary Marcus, Frances Haugen, Steven Pinker, Sneha Revanur, Chris Weitz, Marietje Schaake, and Oren Etzioni.
Press Release
Digital Experience
AI chip deals remain low; chip makers take over as major buyers, reveals new Omdia research
Feb 21, 2024
LONDON, Feb. 21, 2024 /PRNewswire/ -- With demand for AI chips soaring, Omdia's AI Processors Mergers & Acquisitions Tracker has revealed that AI chip deals remain low and that chip manufacturers are taking over as the major buyers. The second edition of Omdia's six-monthly tracker monitors mergers and acquisitions activity involving a core group of major technology companies involved in AI infrastructure and silicon globally.
Press Release
Digital Experience
Windward Maritime AI partners with INTERPOL to Help Combat Global Maritime Crime
Feb 21, 2024
Windward chosen by INTERPOL, the world's largest international police organization, to enhance its global efforts to address illegal activities at sea and create a safer maritime environment LONDON, Feb. 21, 2024 /PRNewswire/ -- Windward (LSE: WNWD), the leading Maritime AI™ company, has announced a partnership with INTERPOL, The International Criminal Police Organization, to assist in their mission of facilitating a secure maritime environment. Windward's Maritime AI will provide valuable intelligence and insights to help identify, track, and prevent criminal activities such as illicit trafficking, human smuggling, and illegal fishing, creating a more secure maritime environment.
Press Release
Digital Experience
The9 Signed a Legally Binding Term Sheet with a Leading AI SaaS Legal Service Platform 365LAWHELP.COM
Feb 21, 2024
SHANGHAI, Feb. 21, 2024 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that it signed a legally binding term sheet (the "Term Sheet") with Zhejiang Fazhidao Information Technology Co., Ltd. ("Fazhidao") to purchase 19% shares of Fazhidao by cash and issuance of The9's restricted shares. The9 is also granted a purchase option to purchase up to 51% of the total shares of Fazhidao, based on a valuation calculated as 7 times of Fazhidao's audited annual profit after tax, provided that such valuation should be higher than a pre-agreed valuation.
Press Release
Digital Experience
ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR
Feb 21, 2024
AI-Supported Screening Delivering Real-World Clinical Results in Research Studies being Presented at ECR VIENNA, Feb. 21, 2024 /PRNewswire/ -- ScreenPoint Medical is showcasing its industry leading Transpara Breast AI at the 2024 European Congress of Radiology (ECR) meeting, February 28-March 3, 2024 (Booth #AI-31 in Expo Hall X1). Transpara provides radiologists with a 'second pair' of eyes to help detect cancers earlier and reduce recall rates.
Press Release
Digital Experience
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets
Feb 21, 2024
OSAKA, Japan, Feb. 20, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. ( Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a research collaboration agreement with InveniAI ® LLC ( Guilford, Connecticut, USA; President and CEO: Krishnan Nandabalan; "InveniAI"), to identify novel therapeutic targets by leveraging cutting-edge InveniAI's artificial intelligence (AI) and machine learning (ML). Under the terms of the agreement, InveniAI will identify novel therapeutic targets in multiple diseases specified by Ono by leveraging InveniAI's AlphaMeld ® and ChatAlphaMeld TM, its AI drug discovery platforms including cutting-edge technologies, such as powerful AI and ML algorithms and Generative AI tools, and propose drug discovery hypotheses for optimization.